BPA Call W81XWH22A0005-HT942726FE032
Award Date 3/24/26
Potential Completion Date 4/14/26
Potential Value $215K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Ann Arbor, MI 48103, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $609.67K firm fixed-price call under its $5.3M blanket purchase agreement with Biodiscovery LLC (doing business as Daicel Arbor Biosciences) for custom MYBAITS kits, with an ultimate completion date of May 28, 2025. This contract utilizes no set-aside designation and represents a task order delivery against the existing BPA vehicle established with the Ann Arbor, Michigan-based vendor. MYBAITS custom DNA reagents and sequencing kits are specialized genomic...
- The Defense Health Agency awarded a $92,550 firm fixed-price call under its $5.3 million Blanket Purchase Agreement with Biodiscovery LLC (doing business as Daicel Arbor Biosciences) on May 24, 2024, with an ultimate completion date of June 18, 2024. The contract, which carries no set-aside designation, calls for the delivery of MYBAITS MITO 384 RXN reagent kits in a quantity of six units. MYBAITS reagents are proprietary custom DNA and RNA-based bait enrichment kits used for targeted genomic...
- The Defense Health Agency awarded a $368,160 firm-fixed-price BPA call to Biodiscovery LLC (doing business as Daicel Arbor Biosciences) on July 11, 2024, for the delivery of custom MYBAITS reagents in quantities of 160,000 to 180,000 units. The contract, which carries an ultimate completion date of July 26, 2024, is not designated as a small business set-aside and represents a task order under the Defense Health Agency's existing $5.3 million blanket purchase agreement with Biodiscovery LLC....
- The Defense Health Agency awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $183,445 to Biodiscovery LLC (doing business as Daicel Arbor Biosciences) on May 5, 2023, for DNA MYBAITS custom reagents. This contract, with an ultimate completion date of February 29, 2024, was awarded without a set-aside designation, allowing the vendor to compete openly in the federal marketplace. The work will be performed at Biodiscovery's facility in Ann Arbor, Michigan. MYBAITS...
- The Defense Health Agency awarded a $46,320 firm fixed-price call under its existing Blanket Purchase Agreement with Biodiscovery LLC (doing business as Daicel Arbor Biosciences) for custom target enrichment kits. This contract, with an ultimate completion date of September 28, 2025, represents a task order under DHA's larger $5.3 million BPA with the vendor, which runs through September 27, 2027. The call carries no small business set-aside designation, allowing Biodiscovery to compete openly...
- The Defense Health Agency awarded a $32,445 firm fixed-price Blanket Purchase Agreement call to Biodiscovery LLC (doing business as Daicel Arbor Biosciences) on June 9, 2023, for the delivery of custom MYBAITS reagents in quantities of 1 to 20,000 units. The contract, which is not set-aside for any small business category, has an ultimate completion date of June 29, 2023, with all work performed at Biodiscovery's facility in Ann Arbor, Michigan. This award represents a task order issued under...
- The Defense Health Agency awarded a firm fixed-price delivery order valued at $27,470 to Biodiscovery LLC (doing business as Daicel Arbor Biosciences) on March 4, 2024, for MYBAITS human whole genome enrichment reagents, specifically 96 reaction quantity 2 and associated reagents. This contract award was issued as a call under an existing Blanket Purchase Agreement and does not utilize a small business set-aside designation. The work will be performed at the contractor's facility in Ann Arbor,...
- The Defense Health Agency awarded a $185,010 firm fixed-price task order to Biodiscovery LLC (doing business as Daicel Arbor Biosciences) on January 29, 2026, for custom target enrichment kits with an ultimate completion date of March 27, 2026. This contract is issued as a call under the agency's existing $5.3 million Blanket Purchase Agreement with Biodiscovery, which enables the DHA to procure the company's proprietary MYBAITS custom DNA reagents and sequencing kits on a firm fixed-price...
- This is a firm fixed price contract awarded by the Defense Health Agency to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, for the delivery of customized MYBAITS-1-768-B DNA reagents. The contract has a potential value of $298,250.00 and a completion date of June 18, 2021. It was issued as a call against Biodiscovery's $5.3 million single-award blanket purchase agreement with the Defense Health Agency, which runs through September 2027. The reagents provided under this contract...
- The Defense Health Agency awarded a $21,485 firm fixed-price call against its Blanket Purchase Agreement with Biodiscovery LLC (doing business as Daicel Arbor Biosciences) on June 27, 2023, with completion expected by September 30, 2023. This task order procures MYBAITS custom reagents, a proprietary molecular biology product manufactured exclusively by Biodiscovery for forensic casework applications. The award was made without a set-aside designation, allowing Biodiscovery to compete openly...
- W81XWH22A0005Blanket Purchase Agreement
- W81XWH22A0005-HT942726FE032BPA Call
The Defense Health Agency issued a BPA call to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, for MYBAITS custom target enrichment kits with a ceiling value of $215,236 and an award date of March 24, 2026. The call is issued under the Defense Health Agency's $5.3 million Blanket Purchase Agreement for custom DNA and MYBAITS reagents, which runs through September 27, 2027 and permits firm-fixed-price delivery orders for proprietary genomic products and sequencing kits supporting biomedical research and diagnostic development. Performance occurs at Biodiscovery's facility in Ann Arbor, Michigan. The call completes April 14, 2026. No set-aside was applied.
Generated 6/22/26, 10:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $215.2k | 3/23/26 |